These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 16013572)

  • 1. [High performance liquid chromatographic analysis of DL-hydroxyphenyl hydantoin and its products converted by engineered bacteria].
    Niu L; Shi Y; Ji Y; Yuan J
    Se Pu; 2005 Mar; 23(2):208. PubMed ID: 16013572
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of stereospecific conversion of DL-5-substituted hydantoins to the corresponding L-amino acids by Pseudomonas sp. strain NS671.
    Ishikawa T; Watabe K; Mukohara Y; Nakamura H
    Biosci Biotechnol Biochem; 1997 Jan; 61(1):185-7. PubMed ID: 9028051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of Tic-hydantoin enantiomers, potent sigma-1 agonists, by high performance liquid chromatography and capillary electrophoresis.
    Cabordery AC; Toussaint M; Bonte JP; Melnyk P; Vaccher C; Foulon C
    J Chromatogr A; 2010 Jun; 1217(24):3871-5. PubMed ID: 20451916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.
    Küpfer A; James R; Carr K; Branch R
    J Chromatogr; 1982 Oct; 232(1):93-100. PubMed ID: 7142342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1957 Jan; 119(1):1-11. PubMed ID: 13457357
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete conversion of D,L-5-monosubstituted hydantoins with a low velocity of chemical racemization into D-amino acids using whole cells of recombinant Escherichia coli.
    Martinez-Rodriguez S; Las Heras-Vazquez FJ; Clemente-Jimenez JM; Mingorance-Cazorla L; Rodriguez-Vico F
    Biotechnol Prog; 2002; 18(6):1201-6. PubMed ID: 12467452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.
    Toussaint M; Mousset D; Foulon C; Jacquemard U; Vaccher C; Melnyk P
    Eur J Med Chem; 2010 Jan; 45(1):256-63. PubMed ID: 19875205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of nitrofurantoin oral suspensions contaminated with 3-(5-nitrofurfurylideneamino)hydantoic acid.
    Juenge EC; Kreienbaum MA; Gurka DF
    J Pharm Sci; 1985 Jan; 74(1):100-2. PubMed ID: 3981405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
    Bius DL; Yonekawa WD; Kupferberg HJ; Cantor F; Dudley KH
    Drug Metab Dispos; 1980; 8(4):223-9. PubMed ID: 6105055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 1,3-dimethylol-5,5-dimethylhydantoin and its decomposition products in cosmetics by high-performance liquid chromatography.
    Asada A; Doi T; Takeda A; Kajimura K
    J Pharm Biomed Anal; 2012; 67-68():163-8. PubMed ID: 22633837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of spirohydantoin mustard in a clinically acceptable formulation of fat emulsion.
    Rose LM; James RH; Duncan MS; Struck RF
    J Chromatogr; 1982 Sep; 246(1):152-6. PubMed ID: 7142343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thin-layer chromatographic identification of some urea- and hydantoin-derivatives].
    Paulus W; Goenechea S; Buttler R
    Arzneimittelforschung; 1969 Mar; 19(3):388-90. PubMed ID: 4388764
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorous mixture synthesis of fused-tricyclic hydantoins. Use of a redundant tagging strategy on fluorinated substrates.
    Manku S; Curran DP
    J Org Chem; 2005 May; 70(11):4470-3. PubMed ID: 15903326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codessa-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities.
    Katritzky AR; Perumal S; Petrukhin R; Kleinpeter E
    J Chem Inf Comput Sci; 2001; 41(3):569-74. PubMed ID: 11410031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional surface properties of an antimicrobial hydantoin at the air-water interface: an experimental and theoretical study.
    Mandal A; Krishnan RS; Thennarasu S; Panigrahi S; Mandal AB
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):136-41. PubMed ID: 20417067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-electrospray ionization mass spectrometry of 4-(3-pyridinylmethylaminocarboxypropyl) phenylthiohydantoins.
    Hess D; Nika H; Chow DT; Bures EJ; Morrison HD; Aebersold R
    Anal Biochem; 1995 Jan; 224(1):373-81. PubMed ID: 7710095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete NMR elucidation of a novel trishomocubane hydantoin and its mono- and bis-t-Boc protected derivatives.
    Fourie L; Govender T; Hariprakasha HK; Kruger HG; Raasch T
    Magn Reson Chem; 2004 Jul; 42(7):617-23. PubMed ID: 15181632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photostability of Iiovaline and its precursor 5-Ethyl-5- methylhydantoin exposed to simulated space radiations.
    Sarker PK; Takahashi JI; Kawamoto Y; Obayashi Y; Kaneko T; Kobayashi K
    Int J Mol Sci; 2012; 13(1):1006-1017. PubMed ID: 22312300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirodihydantoin is a minor product of 5-hydroxyisourate in urate oxidation.
    Yu H; Niles JC; Wishnok JS; Tannenbaum SR
    Org Lett; 2004 Sep; 6(19):3417-20. PubMed ID: 15355066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A rapid analytical method for the determination of hydantoin derivatives in drugs by gas chromatography].
    Erdey L; Dessouky YM; Káplár L; Takács J
    Acta Pharm Hung; 1970 May; 40(3):102-7. PubMed ID: 5430260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.